Structural basis for bifunctional peptide recognition at human δ-opioid receptor

Serial femtosecond crystallography of the human δ-opioid receptor in complex with an endomorphin-derived peptide reveals interactions that are important for understanding the pharmacology of opioid peptides and developing analgesics with reduced side effects. Bifunctional μ- and δ-opioid receptor (O...

Full description

Saved in:
Bibliographic Details
Published inNature structural & molecular biology Vol. 22; no. 3; pp. 265 - 268
Main Authors Fenalti, Gustavo, Zatsepin, Nadia A, Betti, Cecilia, Giguere, Patrick, Han, Gye Won, Ishchenko, Andrii, Liu, Wei, Guillemyn, Karel, Zhang, Haitao, James, Daniel, Wang, Dingjie, Weierstall, Uwe, Spence, John C H, Boutet, Sébastien, Messerschmidt, Marc, Williams, Garth J, Gati, Cornelius, Yefanov, Oleksandr M, White, Thomas A, Oberthuer, Dominik, Metz, Markus, Yoon, Chun Hong, Barty, Anton, Chapman, Henry N, Basu, Shibom, Coe, Jesse, Conrad, Chelsie E, Fromme, Raimund, Fromme, Petra, Tourwé, Dirk, Schiller, Peter W, Roth, Bryan L, Ballet, Steven, Katritch, Vsevolod, Stevens, Raymond C, Cherezov, Vadim
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.03.2015
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Serial femtosecond crystallography of the human δ-opioid receptor in complex with an endomorphin-derived peptide reveals interactions that are important for understanding the pharmacology of opioid peptides and developing analgesics with reduced side effects. Bifunctional μ- and δ-opioid receptor (OR) ligands are potential therapeutic alternatives, with diminished side effects, to alkaloid opiate analgesics. We solved the structure of human δ-OR bound to the bifunctional δ-OR antagonist and μ-OR agonist tetrapeptide H-Dmt-Tic-Phe-Phe-NH 2 (DIPP-NH 2 ) by serial femtosecond crystallography, revealing a cis -peptide bond between H-Dmt and Tic. The observed receptor-peptide interactions are critical for understanding of the pharmacological profiles of opioid peptides and for development of improved analgesics.
Bibliography:U54 GM094618; R01 GM108635; R01 GM095583; DA-004443; Y1-CO-1020
USDOE Office of Science (SC), Basic Energy Sciences (BES)
National Institutes of Health (NIH)
Present address: Center for Applied Structural Discovery at the Biodesign Institute, Arizona State University, Tempe, Arizona, USA
Present address: National Science Foundation BioXFEL Science and Technology Center, Buffalo, New York, USA
Present address: The Bridge@USC, University of Southern California, Los Angeles, California, USA
Present address: Celgene Corporation, San Diego, California, USA
ISSN:1545-9993
1545-9985
DOI:10.1038/nsmb.2965